Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1972 Jul 8;107(1):38–41.

Chlormadinone acetate and its effect on the hemostatic mechanism

A M Wodzicki, A T Coopland
PMCID: PMC1940691  PMID: 4114470

Abstract

There is an apparent discrepancy between the effects on the hemostatic mechanism of synthetic progestins alone and synthetic progestins in combination with synthetic estrogens. Coagulation studies were carried out on 21 patients treated with chlormadinone acetate 0.5 mg. on a continuous daily basis for 12 weeks in order to determine its effects on hemostasis. Unlike the standard estrogen/progestin contraceptive agents, this synthetic progestin appears to have no effect on the coagulation system as determined by standard laboratory tests.

Full text

PDF
38

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTRUP T., BRAKMAN P., NISSEN U. THE ESTIMATION OF FIBRINOGEN. A REVISION. Scand J Clin Lab Invest. 1965;17:57–65. doi: 10.3109/00365516509077284. [DOI] [PubMed] [Google Scholar]
  2. Ambrus J. L., Niswander K. R., Courey N. G., Wamsteker E. F., Mink I. B. Progestational agents and blood coagulation. II. Am J Obstet Gynecol. 1969 Apr 1;103(7):994–1001. doi: 10.1016/s0002-9378(16)34451-9. [DOI] [PubMed] [Google Scholar]
  3. Amris C. J., Starup J. The coagulation mechanism in oral contraception. Acta Obstet Gynecol Scand. 1967;46(1):78–91. doi: 10.3109/00016346709158628. [DOI] [PubMed] [Google Scholar]
  4. BRAKMAN P., ASTRUP T. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD. Lancet. 1964 Jul 4;2(7349):10–12. doi: 10.1016/s0140-6736(64)90005-4. [DOI] [PubMed] [Google Scholar]
  5. Beller F. K., Porges R. F. Blood coagulation and fibrinolytic enzyme studies during cyclic and continuous application of progestational agents. Am J Obstet Gynecol. 1967 Feb 15;97(4):448–459. doi: 10.1016/0002-9378(67)90556-x. [DOI] [PubMed] [Google Scholar]
  6. Brakman P., Albrechtsen O. K., Astrup T. Blood coagulation, fibrinolysis, and contraceptive hormones. JAMA. 1967 Jan 9;199(2):69–74. [PubMed] [Google Scholar]
  7. Brakman P., Sobrero A. J., Astrup T. Effects of different systemic contraceptives on blood fibrinolysis. Am J Obstet Gynecol. 1970 Jan 15;106(2):187–192. doi: 10.1016/0002-9378(70)90261-9. [DOI] [PubMed] [Google Scholar]
  8. Butler C., Hill H. Chlormadinone acetate as oral contraceptive. A clinical trial. Lancet. 1969 Jun 7;1(7606):1116–1119. doi: 10.1016/s0140-6736(69)91641-9. [DOI] [PubMed] [Google Scholar]
  9. CASPARY E. A., PEBERDY M. ORAL CONTRACEPTION AND BLOOD-PLATELET ADHESIVENESS. Lancet. 1965 May 29;1(7396):1142–1143. doi: 10.1016/s0140-6736(65)91960-4. [DOI] [PubMed] [Google Scholar]
  10. Christie G. A. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive. Med J Aust. 1969 Jul 26;2(4):185–189. [PubMed] [Google Scholar]
  11. DONAYRE J., PINCUS G. EFFECTS OF ENOVID ON BLOOD CLOTTING FACTORS. Metabolism. 1965 Mar;14:SUPPL–SUPPL:421. doi: 10.1016/0026-0495(65)90028-4. [DOI] [PubMed] [Google Scholar]
  12. HOUGIE C., RUTHERFORD R. N., BANKS A. L., COBURN W. A. EFFECT OF A PROGESTIN-ESTROGEN ORAL CONTRACEPTIVE ON BLOOD CLOTTING FACTORS. Metabolism. 1965 Mar;14:SUPPL–SUPPL:417. doi: 10.1016/0026-0495(65)90027-2. [DOI] [PubMed] [Google Scholar]
  13. Hilden M., Amris C. J., Starup J. The haemostatic mechanism in oral contraception. Acta Obstet Gynecol Scand. 1967;46(4):562–571. doi: 10.3109/00016346709158656. [DOI] [PubMed] [Google Scholar]
  14. Howard G., Blair M., Elstein M., Morris N. F. Low-dose continuous chlormadinone acetate as an oral contraceptive. A clinical trial. Lancet. 1969 Jul 5;2(7610):24–26. doi: 10.1016/s0140-6736(69)92599-9. [DOI] [PubMed] [Google Scholar]
  15. Hunter D. T., Allensworth J. L. Improved coagulation screening by an activated recalcification test. J Clin Pathol. 1967 May;20(3):244–248. doi: 10.1136/jcp.20.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MARGULIS R. R., AMBRUS J. L., MINK I. B., STRYKER J. C. PROGESTATIONAL AGENTS AND BLOOD COAGULATION. Am J Obstet Gynecol. 1965 Sep 15;93:161–166. [PubMed] [Google Scholar]
  17. MILLER S. P., LEE S. L., RITZ N. PROGESTIN-ESTROGEN (SC 11,800) THERAPY AND THE HEMOSTATIC MECHANISM--A CONTROLLED STUDY. Metabolism. 1965 Mar;14:SUPPL–SUPPL:410. doi: 10.1016/0026-0495(65)90026-0. [DOI] [PubMed] [Google Scholar]
  18. Macdonald R. R., Lumley I. B., Coulson A., Stitch S. R. Chlormadinone acetate as an oral contraceptive: clinical results and the incidence of ovulation. J Obstet Gynaecol Br Commonw. 1968 Nov;75(11):1123–1127. doi: 10.1111/j.1471-0528.1968.tb02895.x. [DOI] [PubMed] [Google Scholar]
  19. Nilsson I. M., Kullander S. Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand. 1967;46(3):286–303. doi: 10.3109/00016346709158633. [DOI] [PubMed] [Google Scholar]
  20. POWELL L. C., Jr, GUEST M. M., BOND T. P. COAGULATION AND FIBRINOLYTIC STUDIES IN WOMEN RECEIVING AN ANOVULATORY DRUG (MEDROXYPROGESTERONE ACETATE WITH ESTRADIOL). Am J Obstet Gynecol. 1965 Sep 15;93:167–172. doi: 10.1016/0002-9378(65)90654-x. [DOI] [PubMed] [Google Scholar]
  21. Poller L., Priest C. M., Thomson J. M. Platelet aggregation during oral contraception. Br Med J. 1969 Nov 1;4(5678):273–274. doi: 10.1136/bmj.4.5678.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Poller L., Thomson J. M., Tabiowo A., Priest C. M. Progesterone oral contraception and blood coagulation. Br Med J. 1969 Mar 1;1(5643):554–556. doi: 10.1136/bmj.1.5643.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Poller L., Thomson J. M., Thomas W., Wray C. Blood clotting and platelet aggregation during oral progestogen contraception: a follow-up study. Br Med J. 1971 Mar 27;1(5751):705–707. doi: 10.1136/bmj.1.5751.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. RUTHERFORD R. N., HOUGIE C., BANKS A. L., COBURN W. A. THE EFFECTS OF SEX STEROIDS AND PREGNANCY ON BLOOD COAGULATION FACTORS. A COMPARATIVE STUDY. Obstet Gynecol. 1964 Dec;24:886–892. [PubMed] [Google Scholar]
  25. Robinson R. W. Effect of estrogen-progestin combinations on clotting factors. Am J Obstet Gynecol. 1967 Sep 15;99(2):163–167. doi: 10.1016/0002-9378(67)90315-8. [DOI] [PubMed] [Google Scholar]
  26. SALZMAN E. W. MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE. J Lab Clin Med. 1963 Nov;62:724–735. [PubMed] [Google Scholar]
  27. SOBRERO A. J., FENICHEL R. L., SINGHER H. O. Effects of a progestin-estrogen preparation on blood coagulation mechanisms. JAMA. 1963 Jul 13;185:136–139. doi: 10.1001/jama.1963.03060020096037. [DOI] [PubMed] [Google Scholar]
  28. Schiffman S., Rapaport S. I. Increased factor 8 levels in suspected carriers of hemophilia A taking contraceptives by mouth. N Engl J Med. 1966 Sep 15;275(11):599–599. doi: 10.1056/NEJM196609152751108. [DOI] [PubMed] [Google Scholar]
  29. Schrogie J. J., Solomon H. M., Zieve P. D. Effect of oral contraceptives on vitamin K-dependent clotting activity. Clin Pharmacol Ther. 1967 Sep-Oct;8(5):670–675. doi: 10.1002/cpt196785670. [DOI] [PubMed] [Google Scholar]
  30. THOMSON J. M., POLLER L. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. Br Med J. 1965 Jul 31;2(5456):270–273. doi: 10.1136/bmj.2.5456.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tyler E. T., Matsner E. M., Gotlib M., Levin M., Tucker J. S., Parrott F. M. Oral contraception by the sequential approach. JAMA. 1966 Sep 19;197(12):943–948. [PubMed] [Google Scholar]
  32. Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J. 1968 Apr 27;2(5599):199–205. doi: 10.1136/bmj.2.5599.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. WOLF P., WALTON K. W. INVESTIGATION OF A QUANTITATIVE ANOMALY ENCOUNTERED IN THE ASSAY OF FIBRINOGEN BY IMMUNO-DIFFUSION. Immunology. 1965 Jan;8:6–24. [PMC free article] [PubMed] [Google Scholar]
  34. Ygge J., Brody S., Korsan-Bengtsen K., Nilsson L. Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study. Am J Obstet Gynecol. 1969 May 1;104(1):87–98. doi: 10.1016/s0002-9378(16)34145-x. [DOI] [PubMed] [Google Scholar]
  35. Zañartu J. Improving the acceptability of oral continuous progestogens in microdosage for fertility control. Br Med J. 1967 Dec 30;4(5582):771–772. doi: 10.1136/bmj.4.5582.771. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES